Month: October 2024

The Role of Immunogenicity in Biologic Drug Development

Introduction Biologic drugs derived from living organisms hold the potential to revolutionize modern medicine. They offer targeted treatments for various diseases, including cancer, autoimmune disorders, and genetic conditions. These large, complex molecules, such as proteins, antibodies, and vaccines, can precisely interact with specific cellular targets, opening new possibilities for treatment and care. This potential for revolutionizing healthcare…

Read More...

Cell-Based vs. Non-Cell-Based NAb Assays: Which Method is Right for Your Research?

Your research on neutralizing antibodies (NAbs) is of utmost importance, as these antibodies can inhibit or block the biological/pharmacological activity of the drug in vivo, potentially impacting its efficacy. This potential impact underscores the urgency and importance of your work. Of most significant concern are antibodies that neutralize the administered drug and neutralize an essential non-redundant…

Read More...

Best Practices for Optimizing NAB Assay Performance with Suggestions for Improved Accuracy & Efficiency

Introduction Neutralizing antibody (NAb) assays are critical tools in immunology1. These assays measure the ability of antibodies to neutralize pathogens, such as viruses, by preventing their entry into host cells1,3. NAb assays are essential in drug development, vaccine research, and molecular analysis of immunogenicity measuring NAb for AAVs and immune response monitoring2. They help determine…

Read More...